Like the Sword of Damocles of Greek myth, market price reporting by labs under the Protecting Access to Medicare Act (PAMA) continues to hang over the heads of the nation’s clinical laboratories. However, instead of a threat, PAMA market price reporting may soon become a reality. News reports indicate that, as of April 21, the White …
May 2, 2016 Intelligence: Late Breaking Lab News Read More »
